THOMAS KNUTSON: Open Payments
NPI 1003109745 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 9 payments from 4 companies in 2025. Trend: 2023 $271 · 2024 $77 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| Janssen Pharmaceuticals, Inc | 2 | $62 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| ACADIA Pharmaceuticals Inc | 1 | $17 |
Products named: COBENFY, INVEGA SUSTENNA, FANAPT, NUPLAZID.
Industry payments across AZ — which companies pay providers there.
